Boudewijn van Vliet
Director/Board Member presso PRYME N.V.
Posizioni attive di Boudewijn van Vliet
Società | Posizione | Inizio | Fine |
---|---|---|---|
PRYME N.V. | Director/Board Member | 11/02/2021 | - |
Director of Finance/CFO | - | - | |
Antion Biosciences SA
Antion Biosciences SA BiotechnologyHealth Technology Antion Biosciences SA is a Swiss-based biotechnology company that develops universal cell and gene therapy products to treat diseases with significant unmet medical needs. The private company is based in Geneva, Switzerland. The company's proprietary gene silencing and co-expression gene constructs allow for a modular and tunable approach to multiplex engineering of therapeutic cells. Antion aims to develop off-the-shelf therapies with enhanced potency and improved safety to make cell and gene therapies universal and broaden access to these life-changing therapies for all patients. Antion Biosciences was founded by Michael Pepper and Roberto Speck, and the CEO is Marco Alessandrini. | Director/Board Member | 09/08/2023 | - |
Chairman | - | 09/08/2023 |
Storia della carriera di Boudewijn van Vliet
Statistiche
Distribuzione geografica
Svizzera | 2 |
Paesi Bassi | 2 |
Posizioni
Director/Board Member | 2 |
Director of Finance/CFO | 1 |
Chairman | 1 |
Settori
Health Technology | 2 |
Industrial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
PRYME N.V. | Industrial Services |
Aziende private | 1 |
---|---|
Antion Biosciences SA
Antion Biosciences SA BiotechnologyHealth Technology Antion Biosciences SA is a Swiss-based biotechnology company that develops universal cell and gene therapy products to treat diseases with significant unmet medical needs. The private company is based in Geneva, Switzerland. The company's proprietary gene silencing and co-expression gene constructs allow for a modular and tunable approach to multiplex engineering of therapeutic cells. Antion aims to develop off-the-shelf therapies with enhanced potency and improved safety to make cell and gene therapies universal and broaden access to these life-changing therapies for all patients. Antion Biosciences was founded by Michael Pepper and Roberto Speck, and the CEO is Marco Alessandrini. | Health Technology |
- Borsa valori
- Insiders
- Boudewijn van Vliet
- Esperienza